These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18276710)

  • 1. Should doctors advocate snus and other nicotine replacements? Yes.
    Britton J
    BMJ; 2008 Feb; 336(7640):358. PubMed ID: 18276710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should doctors advocate snus and other nicotine replacements? No.
    Macara AW
    BMJ; 2008 Feb; 336(7640):359. PubMed ID: 18276711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.
    Nelson PR; Chen P; Battista DR; Pillitteri JL; Shiffman S
    Nicotine Tob Res; 2019 Jan; 21(1):88-94. PubMed ID: 29373698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
    Hatsukami DK; Severson H; Anderson A; Vogel RI; Jensen J; Broadbent B; Murphy SE; Carmella S; Hecht SS
    Tob Control; 2016 May; 25(3):267-74. PubMed ID: 25991608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Swedish snus associated with smoking initiation or smoking cessation?
    Furberg H; Bulik CM; Lerman C; Lichtenstein P; Pedersen NL; Sullivan PF
    Tob Control; 2005 Dec; 14(6):422-4. PubMed ID: 16319367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between quick-release nicotine lozenges and Swedish-style snus for the acute management of craving.
    Barrett SP; Wagner E
    Tob Control; 2011 Sep; 20(5):386. PubMed ID: 21610268
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotine replacement therapy, professional therapy, snuff use and tobacco smoking: a study of smoking cessation strategies in southern Sweden.
    Lindström M
    Tob Control; 2007 Dec; 16(6):410-6. PubMed ID: 18048619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum.
    Lunell E; Curvall M
    Nicotine Tob Res; 2011 Jul; 13(7):573-8. PubMed ID: 21454913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of snus in initiation and cessation of tobacco smoking in Sweden.
    Ramström LM; Foulds J
    Tob Control; 2006 Jun; 15(3):210-4. PubMed ID: 16728752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of snus (oral moist snuff ) in smoking cessation and smoking reduction in Sweden.
    Gilljam H; Galanti MR
    Addiction; 2003 Sep; 98(9):1183-9. PubMed ID: 12930201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Product Marketing Blurs the Line Between Nicotine Replacement Therapy and Smokeless Tobacco Products.
    Kostygina G; England L; Ling P
    Am J Public Health; 2016 Jul; 106(7):1219-22. PubMed ID: 27077338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
    Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
    J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Harm reduction strategy in tobacco control].
    Gorini G
    Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Smoking and Snus Use in Sweden: Implications for Public Health.
    Ramström L; Borland R; Wikmans T
    Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27834883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First, tell the truth: a dialogue on human rights, deception, and the use of smokeless tobacco as a substitute for cigarettes.
    Kozlowski LT
    Tob Control; 2003 Mar; 12(1):34-6. PubMed ID: 12612359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misleading conclusions from Altria researchers about population health effects of dual use.
    Glantz SA; Ling PM
    Nicotine Tob Res; 2011 Apr; 13(4):296; author reply 297. PubMed ID: 21350043
    [No Abstract]   [Full Text] [Related]  

  • 18. Snus: part of the problem or part of the solution?
    Ramstrom L
    Addiction; 2003 Sep; 98(9):1198-9; discussion 1204-7. PubMed ID: 12930204
    [No Abstract]   [Full Text] [Related]  

  • 19. RJ Reynolds has not published a negative randomised clinical trial of Camel Snus for smoking cessation.
    Neeley EE; Glantz SA
    Tob Control; 2017 May; 26(3):357-358. PubMed ID: 27207852
    [No Abstract]   [Full Text] [Related]  

  • 20. Snus as a smoking cessation aid: a randomized placebo-controlled trial.
    Fagerstrom K; Rutqvist LE; Hughes JR
    Nicotine Tob Res; 2012 Mar; 14(3):306-12. PubMed ID: 21994343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.